IndraLab
Statements
sparser
"Several mechanisms of intrinsic resistance have been described among whom loss of PTEN, cyclin D1 amplification, loss of NF1, RAC1 P29S mutation, HGF secretion, MAP3K8 overexpression, loss of the USP28–FBW7 complex, low levels of CD8 tumor-infiltrating T cells and increased expression of the immune inhibitory molecule PD-L1 ( xref – xref )."
reach
"31 In another similar study, cross‐linked ORF in circFBXW7, driven by the IRES, was found to encode a new 21‐kDa protein called FBXW7‐185aa.61 FBXW7‐185aa can bind with USP28 to prevent USP28 binding with FBXW7α mRNA, thereby reducing the half‐life of c‐Myc and inhibiting proliferation and cell cycle progression, significantly inhibiting glioma progression (Figure 3C).61
5."
sparser
"This type of resistance involves several key mechanisms ( xref ), including the loss of the phosphatase and TENsin homolog ( PTEN ) gene, amplification of the cyclin D1 ( CCND1 ) gene, Cancer Osaka Thyroid kinase (COT, MAP3K8) overexpression, loss of the neurofibromin 1 ( NF1 ) tumor suppressor gene, mutations in Ras-related C3 botulinum toxin substrate 1 (RAC1P29S), and the disruption of the ubiquitin-specific peptidase 28 (USP28-FBW7) complex."